Pedro Bretcha-Boix
Pedro Bretcha-Boix publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Intraperitoneal and Appendiceal Malignancies, Occupational and environmental lung diseases and Ovarian cancer diagnosis and treatment.
- World rank
- #2,883,090 of 7,710,434 ranked researchers
- Rank in Spain
- #63,968 of 204,306
- Works
- 23
- Citations
- 998
- Citations per work
- 43.4
What does Pedro Bretcha-Boix research?
Pedro Bretcha-Boix's work is mostly in Medicine (82%), Materials Science (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1982.1%
- Medicine1982.1%
- Everything else313.4%
- Physical Sciences14.5%
- Materials Science14.5%
- 1Surgery36% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Oncology13% of their works
- 4Reproductive Medicine9% of their works
- 5Emergency Medicine8% of their works
- 6Biomaterials4% of their works
Research topics
- Intraperitoneal and Appendiceal Malignancies
- Occupational and environmental lung diseases
- Ovarian cancer diagnosis and treatment
- Appendicitis Diagnosis and Management
- Nanoparticle-Based Drug Delivery
- Adrenal and Paraganglionic Tumors
- Neuroendocrine Tumor Research Advances
- Hepatocellular Carcinoma Treatment and Prognosis
Which keywords describe Pedro Bretcha-Boix's research?
The keywords of their largest research topics: Cytoreductive Surgery, Survival Analysis, Colorectal Cancer, Intraperitoneal Chemotherapy, Diagnosis, Management, BAP1 mutations and Genomic Analysis.
- Neuroendocrine Tumors
- Hepatocellular Carcinoma
- Paraganglioma
- Drug Delivery
- Appendicitis
- Ovarian Cancer
- Genomic Analysis
- Management
- Intraperitoneal Chemotherapy
- Survival Analysis
- Cytoreductive Surgery
- Colorectal Cancer
- Diagnosis
- BAP1 mutations
- Malignant Pleural Mesothelioma
- Antibiotic Therapy
- Genetic Mutations
- Nanocarriers
- Pheochromocytoma
- Liver Cancer
- Pancreatic Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cytoreductive Surgery232 topics
- Survival Analysis192 topics
- Colorectal Cancer171 topic
- Intraperitoneal Chemotherapy171 topic
- Diagnosis72 topics
- Management72 topics
- BAP1 mutations61 topic
- Genomic Analysis61 topic
- Malignant Pleural Mesothelioma61 topic
- Ovarian Cancer61 topic
- Antibiotic Therapy51 topic
- Appendicitis51 topic
- Genetic Mutations52 topics
- Drug Delivery31 topic
- Nanocarriers31 topic
- Paraganglioma31 topic
- Pheochromocytoma31 topic
- Hepatocellular Carcinoma21 topic
- Liver Cancer21 topic
- Neuroendocrine Tumors21 topic
- Pancreatic Neuroendocrine Tumors21 topic
Where does Pedro Bretcha-Boix work?
Pedro Bretcha-Boix's main affiliation in the publication record is Hospital Quirón Torrevieja, Spain.
How many publications and citations does Pedro Bretcha-Boix have?
OpenAlex counts 23 works and 998 citations for Pedro Bretcha-Boix, an h-index of 10, ranking #2,883,090 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Pedro Bretcha-Boix
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pedro Bretcha-Boix. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.